<DOC>
	<DOC>NCT00483548</DOC>
	<brief_summary>The purpose of this study is to determine if a treatment regimen of ziprasidone plus a mood stabilizer is safe and effective in the short term treatment of Bipolar I Depression. Ziprasidone will be added to lithium, valproate or lamotrigine after the patient has been on a therapeutic dose of one of these mood stabilizers for at least 4 weeks.</brief_summary>
	<brief_title>Adjunctive Ziprasidone in the Treatment of Bipolar I Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Adults meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) criteria for Bipolar I disorder, most recent episode depressed, with or without rapid cycling and without psychotic features. Subjects receive therapeutic dose of lithium, valproate or lamotrigine for at least 4 weeks prior to randomization. Patients with ultrafast rapid cycling (8 or more mood episodes per year) Significant heart disease including abnormalities in the heart's rhythm (QT prolongation) Psychotic symptoms (hallucinations and/or delusions).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>